Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Zamora

20 clinical trials in Zamora, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Zamora at a glance
20
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

20 trials in Zamora

Open in trial search

Study of Brenipatide (LY3537031) in Adults with Major Depressive Disorder to Evaluate Delay of Relapse Compared with Placebo

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:LY3537031
  • Sponsor:Eli Lilly & Co.

Agitation+1

Recruiting

A study to evaluate the safety and effectiveness of dextromethorphan, deramciclane fumarate, and deramciclane in treating agitation in people with Alzheimer's disease

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Dextromethorphan Hydrobromide

Schizophrenia

Recruiting

Study of evenamide as add-on treatment for patients with treatment-resistant schizophrenia not adequately controlled by current antipsychotic medications

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Evenamide
  • Sponsor:Newron Pharmaceuticals S.p.A.

Schizophrenia

Recruiting

Study on Vafidemstat for Treating Negative Symptoms and Cognitive Impairment in Adults with Schizophrenia

Investigational
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Vafidemstat
  • Sponsor:Oryzon Genomics S.A.

Cholelithiasis

Recruiting

Study comparing low and standard doses of indocyanine green for fluorescence imaging during gallbladder removal surgery in patients with gallstones

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Indocyanine Green
  • Sponsor:Fundacion De Investigacion Biomedica De Salamanca

Study on ITI-1284 for Treating Agitation in Alzheimer's Patients

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:ITI-1284
  • Sponsor:Intra-Cellular Therapies Inc.

Psychotic disorder+2

Recruiting

Study on ITI-1284 for Treating Psychosis in Alzheimer's Patients

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:ITI-1284
  • Sponsor:Intra-Cellular Therapies Inc.

Study on Arbaclofen for Improving Social Function in Children and Adolescents with Autism Spectrum Disorder

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Arbaclofen
  • Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Gregorio Maranon

Psychotic disorder+1

Recruiting

Study on Long-Term Safety of KarXT (Trospium Chloride, Xanomeline Tartrate) for Patients with Alzheimer's-Related Psychosis

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Karuna Therapeutics Inc.

Study on Lumateperone for Patients with Major Depressive Disorder Not Responding to Antidepressants

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Lumateperone
  • Sponsor:Intra-Cellular Therapies Inc.

Long-Term Safety Study of ACP-204 for Adults with Alzheimer's Disease Psychosis

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:ACP-204 tartrate
  • Sponsor:Acadia Pharmaceuticals Inc.

Schizophrenia

Not yet recruiting

Phase 3 Double‑Blind Relapse Prevention Trial of Trospium Chloride and Xanomeline Tartrate (KarXT) in Adults with Schizophrenia

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Other cities in Spain

The busiest research cities in the country

All 214 cities in Spain

Clinical research in Zamora

What the registry says about research in the country

01 Oncology Research

Clinical investigations focusing on metastatic colorectal cancer prevention strategies, particularly examining thromboembolic disease prophylaxis in patients beginning first-line treatment.

  • Colorectal Cancer Stage IV
  • Venous Thromboembolism Prevention

Studies emphasize preventive care approaches for cancer patients undergoing systemic treatment.

02 Mental Health Studies

Comprehensive research into treatment-resistant depression and schizophrenia, evaluating novel therapeutic approaches and long-term safety profiles.

  • Depression Treatment Innovation
  • Schizophrenia Management
  • Cognitive Impairment

Trials focus on developing effective interventions for complex psychiatric conditions.

03 Neurodegenerative Disorders

Innovative research targeting Alzheimer's Disease complications, including psychosis and agitation management in dementia patients.

  • Alzheimer's Psychosis
  • Agitation Management
  • Long-term Treatment Safety

Studies aim to improve quality of life for patients with neurodegenerative conditions.

04 Autism Spectrum Research

Focused investigations into autism spectrum disorders, examining treatments for social function improvement and irritability management in children and adolescents.

  • Social Function Enhancement
  • Behavioral Management
  • Pediatric Applications

Research emphasizes long-term safety and effectiveness in young patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.